InsidersTradesSigma
Track the 바이오포트 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Food & Beverage sector, 바이오포트 has recorded 6 insider filings. Market capitalisation: €23.4bn. The latest transaction was disclosed on 31 August 2026 (Purchase). Among the most active insiders: 한국투자파트너스. All data is free.
4
Insider Decl.
n/a
Thresholds
€5,412
3 ops.
Buy Volume
n/a
1 ops.
Sell Volume
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,026 of 29,064 companies
31.2
score / 100
Value35
Quality27
FCF yld10%
Earn yld-6.0%
EV/EBITDA42.0x
ROE7.3%
Gross mgn24%
Net mgn-2.0%
Debt/EBITDA14.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
Declarations6 total
Other
Other
6 of 6 declarations
关于 바이오포트
Bioport 是一家在 XKRX 上市的农业食品公司。它专注于有机产品的开发和分销。